Dublin, March 04, 2024 (GLOBE NEWSWIRE) — The “Vocal Biomarker Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F” report has been added to ResearchAndMarkets.com’s offering.
The healthcare and technology landscape is witnessing a significant upsurge with the integration of voice analysis and artificial intelligence (AI) used to detect a variety of medical conditions.
The advancement reveals that the Global Vocal Biomarker Market is poised to achieve a remarkable CAGR of 9.32%, starting from its 2022 valuation at USD 2.01 billion through its forecast period ending in 2028.
The non-invasive nature of vocal biomarkers is revolutionizing the medical field, providing personalized treatment and early detection capabilities. This market growth is largely driven by the rising demand for chronic disease and mental health disorder diagnosis and ongoing patient monitoring. Furthermore, the COVID-19 pandemic has placed the spotlight on the need for remote healthcare solutions, reinforcing the significance of vocal biomarkers in telemedicine and patient monitoring practices.
Key Market Drivers: Chronic Disease Prevalence and AI Advancements
Vocal biomarkers are gaining traction in managing prevalent chronic conditions such as diabetes, cardiovascular diseases, respiratory illnesses, and mental health disorders. This technology facilitates remote monitoring of glucose levels, detects cardiovascular stress markers, and assesses mental health status, streamlining early diagnosis and personalized healthcare.
Moreover, advancements in Artificial Intelligence (AI) and Machine Learning (ML) are boosting the market’s potential. AI-driven platforms enable the precise analysis of vocal data for medical applications, including assessments of neurological disorders and the monitoring of respiratory and psychiatric conditions.
Neurological Disorder Diagnosis: A Growing Application Area
With the prevalence of neurological disorders on the rise, vocal biomarkers offer a breakthrough in early diagnosis and real-time monitoring. Detecting speech pattern alterations signifies progress in addressing diseases like Parkinson’s and Alzheimer’s. The non-invasive methodology proves to be patient-friendly, supporting consistent health tracking without invasive procedures.
Privacy Concerns and Standardization: Critical Challenges
Data privacy and security are significant challenges for the vocal biomarker industry. Sensitive voice data requires robust encryption and informed consent processes to ensure users’ privacy. Standards in data collection, analysis techniques, and practices are also required to endorse vocal biomarkers’ reliability in healthcare integration.
Telemedicine and Respiratory Monitoring: Trending Market Dynamics
Telemedicine and remote patient monitoring are reshaping healthcare delivery with vocal biomarkers at their foundation. These trends enable monitoring and managing conditions like asthma and COPD by utilizing vocal parameters to indicate symptom variations, helping in proactive medical responses.
- Technique Insights: Frequency analysis dominates the Global Vocal Biomarker Market due to its significance in diagnosing various conditions and its biological relevance in voice analysis.
- Indication Insights: Neurological disorders hold a major share, thanks to the non-invasive nature of vocal biomarkers, allowing for early detection and continuous disease monitoring.
- Regional Insights: North America leads the market share with ongoing research, technological advancements, and a strong regulatory framework guiding vocal biomarker applications.
The future of the Global Vocal Biomarker Market is characterized by innovations that marry voice data analysis with technology, enhancing clinical accuracy and extending the reach of patient care across diverse medical disciplines.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2022 – 2028 |
| Estimated Market Value (USD) in 2022 | $2.01 Billion |
| Forecasted Market Value (USD) by 2028 | $3.41 Billion |
| Compound Annual Growth Rate | 9.3% |
| Regions Covered | Global |
Report Scope:
In this report, the Global Vocal Biomarker Market has been segmented into the following categories:
Global Vocal Biomarker Market, By Technique:
- Frequency
- Amplitude
- Error Rate
- Vocal Rise or Fall Time
- Phonation Time
- Vocal Tremor
- Pitch
- Others
Global Vocal Biomarker Market, By Indication:
- Psychiatric Disorders
- Respiratory Disorders
- Cardiovascular Disorders
- Traumatic Brain Injury (TBI)
- Neurological disorders
- Other
Global Vocal Biomarker Market, By End User:
- Hospitals & clinics
- Ambulatory Surgical Services
- Others
Companies Profiled
- IBM
- Boston Technology Corporation
- EVOCAL Health
- Audio Profiling
- Cogito Corporation
- Kintsugi
- Sharecare Inc.
- Microtest Health
- Sonde Health
- AudEERING
For more information about this report visit https://www.researchandmarkets.com/r/cctebl
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Global Vocal Biomarker Market
